HAE — Haemonetics Corporation stock price, charts and financials

QT75Haemonetics Corporation

Haemonetics Corporation (NYSE: HAE) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
86.61
-1.23-1.40%
OverviewShort InterestFilings
HAEQT75Haemonetics Corporation·NYSE
86.61-1.40%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 28, 20268-KCurrent report
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20263Initial statement of beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jun 09, 2026DEFA14AAdditional proxy soliciting materials
Jun 09, 2026ARSAnnual report to shareholders
Jun 09, 2026DEF 14ADefinitive proxy statement
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
May 28, 2026SDSpecialized disclosure report
May 20, 202610-KAnnual report
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
#1 / 25 of 329
Page
▼
/ 14